Insider Shareholders with Direct Ownership of Roivant Sciences Ltd. (ROIV)
This section provides a comprehensive overview of the insiders with direct ownership of Roivant Sciences Ltd. (ROIV). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Roivant Sciences Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Dexcel Pharma Technologies Ltd.
> 10% Shareholder |
4,040,285 | 0 | 102,849,443 $1.09 Billion | 3 |
Nov 10, 2022
Added 3.74%
|
|
Vivek Ramaswamy
> 10% Shareholder |
1,029,735 | 20,867,377 | 51,929,426 $550 Million | 13 |
Jan 02, 2024
Reduced 5.46%
|
|
Mayukh Sukhatme
Pres&Chief Investment Officer |
21,128,839 | 5,317,017 | 18,836,547 $200 Million | 17 |
Dec 26, 2024
Reduced 3.53%
|
|
Matthew Gline
CEO |
19,290,133 | 3,655,145 | 17,316,601 $184 Million | 54 |
Feb 20, 2025
Reduced 0.06%
|
| 86,373 | 3,309,862 | 7,289,093 $77.3 Million | 7 |
Sep 12, 2024
Reduced 0.04%
|
|
| 86,373 | 503,000 | 1,277,178 $13.5 Million | 5 |
Sep 25, 2024
Reduced 9.56%
|
|
|
Eric Venker
President & COO |
5,800,950 | 6,304,019 | 885,924 $9.39 Million | 120 |
Feb 20, 2025
Reduced 1.22%
|
|
Richard Pulik
CFO |
105,395 | 65,672 | 270,680 $2.87 Million | 30 |
Jan 28, 2025
Reduced 0.7%
|
|
Rakhi Kumar
Chief Accounting Officer |
962,535 | 1,065,460 | 162,306 $1.72 Million | 73 |
Feb 20, 2025
Reduced 0.59%
|
| 112,701 | 12,772 | 99,929 $1.06 Million | 19 |
Jan 23, 2025
Reduced 0.31%
|
|
| 105,708 | 11,094 | 94,607 $1 Million | 19 |
Jan 23, 2025
Reduced 0.32%
|
|
| 52,142 | 0 | 52,142 $552,705 | 1 |
Sep 15, 2022
Added 50.0%
|
|
| 44,077 | 4,548 | 39,529 $419,007 | 12 |
Jan 23, 2025
Reduced 0.45%
|
|
| 30,353 | 977 | 29,376 $311,385 | 8 |
Sep 12, 2024
Reduced 2.95%
|